NCT03523520View on ClinicalTrials.gov

Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 23, 2020

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Constipation Drug Induced
Interventions
DRUG

Methylnaltrexone Bromide 150 mg Oral Tablet

Methylnaltrexone Bromide 150 mg Oral Tablet

DRUG

Methylnaltrexone Bromide 12 MG/0.6 ML Subcutaneous Solution [RELISTOR]_#1

Methylnaltrexone Bromide 12 MG Subcutaneous Solution

DRUG

Naloxegol 25 MG Oral Tablet

Naloxegol 25 MG Oral Tablet

Trial Locations (1)

65212

Kara B. Goddard, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT03523520 - Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation | Biotech Hunter | Biotech Hunter